Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
publishDate:"[2021 TO 2021]"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=publishDate%3A%22%5B2021+TO+2021%5D%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields&page=10
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=publishDate%3A%22%5B2021+TO+2021%5D%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields&page=10
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=publishDate%3A%22%5B2021+TO+2021%5D%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields&page=10
PubPharm (1.746)
91
Efficacy and Safety of Three Inhaled Dose Levels of AZD1402 Twice Daily for Four Weeks in Adults with Asthma on Medium Dose Inhaled Corticosteroids : A Two-part Phase IIa Randomised, Double-blind, Placebo-controlled, Dose ranging, Multi centre Study to Assess Efficacy and Safety of Three Inhaled Dose Levels of AZD1402 Administered as a Dry Powder Twice Daily for Four Weeks in Adults with Asthma on Medium Dose Inhaled Corticosteroids - APATURA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
92
Efficacy and safety study of corticosteroids plus hydroxychloroquine in first-line treatment of patients with primary immune thrombocytopenia with positive antinuclear antibody : Efficacy and safety study of corticosteroids plus hydroxychloroquine in first-line treatment of patients with primary immune thrombocytopenia with positive antinuclear antibody
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
93
Prophylactic effect of ramosetron and dexamethasone on the occurrence of postoperative vomiting : Effects of dexamethasone and ramosetron (Nasea®) on prevention of postoperative nausea and vomiting in low risk patients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
94
Prophylactic effect of ramosetron and dexamethasone on the occurrence of postoperative vomiting : Effects of dexamethasone and ramosetron (Nasea®) on prevention of postoperative nausea and vomiting in low risk patients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
95
Activity, safety and pharmacokinetics in pediatric subjects with moderate and severe chronic graft vs. host disease after allogeneic stem cell transplant : A Phase II open-label, single-arm, multi-center study of ruxolitinib added to corticosteroids in pediatric subjects with moderate and severe chronic graft vs. host disease after allogeneic stem cell transplantation
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
96
Pomalidomide/Dexamethasone With or Without Elotuzumab in Multiple Myeloma that is resistant to treatment. : An Open Label, Randomized Phase 2 Trial of Pomalidomide/Dexamethasone With or Without Elotuzumab in relapsed and refractory Multiple Myeloma.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
97
Ropivacain 0,2% plus Dexamethason versus Ropivacain 0,2% plus Placebo in modified pectoral block - A randomized, double-blind, prospective trial : Ropivacain 0,2% plus Dexamethason versus Ropivacain 0,2% plus Placebo in modified pectoral block - A randomized, double-blind, prospective trial
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
98
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF LEBRIKIZUMAB WHEN USED IN COMBINATION WITH TOPICAL CORTICOSTEROID TREATMENT IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS : A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF LEBRIKIZUMAB WHEN USED IN COMBINATION WITH TOPICAL CORTICOSTEROID TREATMENT IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS - ADhere
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
99
Panobinostat with bortezomib and dexamethasone in relapsed or relapsed-and-refractory multiple myeloma : A multicenter, randomized, open-label Phase 2 study evaluating the safety and efficacy of three different regimens of oral panobinostat in combination with subcutaneous bortezomib and oral dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma who have been previously exposed to immunomodulatory agents
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
100
Treatment of ESES syndrome with corticosteroids or clobazam: a Europeanstudy : Corticosteroids or clobazam for ESES syndrome: a European, multicenter,randomized, controlled clinical trial - RESCUE ESES
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
[1]
« Vorheriger
5
6
7
8
9
10
11
12
13
14
15
Nächster »
[175]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Filter aufheben
Erscheinungsjahr: 2021-2021
Medienart
1.746
Aufsätze
1.746
E-Artikel
1.746
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
1.724
610
1.664
Study Type: Interventional
778
Recruitment Status: Not yet recruiting
506
Phase: Phase 3
344
Recruitment Status: Authorised-recruitment may ...
284
Recruitment Status: Completed
272
Phase: Phase 2
242
Recruitment Status: Recruiting
138
Phase: Phase 4
74
Phase: Phase 1
70
Medical Condition: Health Condition 1: O- Medic...
50
Study Type: Observational
48
Medical Condition: Multiple Myeloma MedDRA vers...
42
Phase: Phase 2/Phase 3
28
Medical Condition: Multiple myeloma MedDRA vers...
28
Phase: Post Marketing Surveillance
24
Medical Condition: Moderate and Severe Atopic D...
22
Medical Condition: Relapsed or Refractory Multi...
22
Medical Condition: corticosteroid-refractory ac...
20
Phase: Phase 3/Phase 4
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2021-2021
Erscheinungsjahr(e)
Von:
Bis:
Sprache
1.688
Englisch
54
Unbestimmt
4
Spanisch
Haven't found what you're looking for?
Wird geladen...